CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

The differentiation between multiple system atrophy (MSA) and Parkinson’s disease (PD) is difficult, particularly in early disease stages. Therefore, we aimed to evaluate the diagnostic value of neurofilament light chain (NFL), fms-like tyrosine kinase ligand (FLT3L), and total tau protein (t-tau) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbert, Megan K., Aerts, Marjolein B., Beenes, Marijke, Norgren, Niklas, Esselink, Rianne A. J., Bloem, Bastiaan R., Kuiperij, H. Bea, Verbeek, Marcel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419719/
https://www.ncbi.nlm.nih.gov/pubmed/25999911
http://dx.doi.org/10.3389/fneur.2015.00091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419719/
https://www.ncbi.nlm.nih.gov/pubmed/25999911
http://dx.doi.org/10.3389/fneur.2015.00091

Ejemplares similares